The data displays the unit sales of the leading internal analgesic tablet brands in the U.S. in 2017. In that year, Excedrin Migraine sold approx. 12.4 million units in the U.S.
Private label | 244.2 |
Advil | 63 |
Aleve | 43.7 |
Tylenol | 41.8 |
Bayer | 34.7 |
BC | 13.3 |
Excedrin Migraine | 12.4 |
Excedrin | 9.8 |
Advil PM | 9.7 |
Motrin IB | 8.4 |